|
|
Volumn 423, Issue , 2008, Pages 405-419
|
|
Electroporation of corrective nucleic acids (CNA) in vivo to promote gene correction in dystrophic muscle.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DYSTROPHIN;
PRIMER DNA;
RECOMBINANT DNA;
ANIMAL;
ANIMAL MUSCULAR DYSTROPHY;
ARTICLE;
DUCHENNE MUSCULAR DYSTROPHY;
ELECTROCHEMOTHERAPY;
FEMALE;
GENE EXPRESSION;
GENE THERAPY;
GENETICS;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
MALE;
METABOLISM;
METHODOLOGY;
MOUSE;
NUCLEOTIDE SEQUENCE;
SKELETAL MUSCLE;
X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;
ANIMALS;
BASE SEQUENCE;
DNA PRIMERS;
DNA, RECOMBINANT;
DYSTROPHIN;
ELECTROCHEMOTHERAPY;
FEMALE;
GENE EXPRESSION;
GENE THERAPY;
HUMANS;
INJECTIONS, INTRAMUSCULAR;
MALE;
MICE;
MICE, INBRED MDX;
MUSCLE, SKELETAL;
MUSCULAR DYSTROPHY, ANIMAL;
MUSCULAR DYSTROPHY, DUCHENNE;
MLCS;
MLOWN;
|
|
EID: 44649107663
PISSN: 10643745
EISSN: None
Source Type: Journal
DOI: 10.1007/978-1-59745-194-9_32 Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
